MMedication Read More This plant extract can make a lethal drug cocktail. Can it also treat opioid addiction?June 19, 2026 A plant extract that’s gaining popularity as a pain cure-all and has been associated with multiple California deaths…
HHealthcare Read More Why Healthcare Stocks Are Primed to Outperform the Market: 2 FirmsJune 16, 2026 Healthcare stocks are typically seen as defensive investments. When things go south for the market, they outperform. That…
EEconomy Read More Top Economist Warns That the US Economy Is Flashing Key Warning SignalJune 5, 2026 The US economy may be growing, but Moody’s chief economist Mark Zandi says that doesn’t mean it’s in…
MMedication Read More Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for UlixacaltamideApril 30, 2026 Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the 10 best biotech stocks with highest upside potential. As…
BBusiness Read More 3 Market Trends That Could Shape the Rest of 2026April 25, 2026 The past few years have featured pretty much just one dominant market theme: artificial intelligence (AI). Stock market…
HHealthcare Read More Green Cross Health confirms potential sale talks for medical divisionApril 14, 2026 Green Cross Health provides access to professional healthcare with over 300 Unichem and Life Pharmacies covering almost every…
HHealthcare Read More Bank of America Says These 2 Healthcare Stocks Are Top Ideas for 1Q26January 7, 2026 As 2026 gets rolling, it’s only natural to want to find the best stocks to boost the portfolio…
MMedication Read More FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)December 29, 2025 PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and…
AArtificial intelligence Read More Index providers anticipate AI and private market potential: S&P DJIDecember 26, 2025 Markets Passive investments grow with money flowing into dividend ETFs in Asia Jason Ye of S&P Dow Jones…
BBusiness Read More How the Narrative Surrounding Prothena Is Changing After New Pipeline and Valuation UpdatesDecember 6, 2025 Prothena’s fair value estimate has been nudged higher from $18.33 to $20.33 per share as analysts grow more…
MMusic Read More ‘KPop Demon Hunters’ creator: Live-action remake wouldn’t workOctober 15, 2025 “KPop Demon Hunters” creator Maggie Kang thinks there’s potential for more Huntr/x stories in the future, but only…
HHealthcare Read More A Look at OneMedNet (ONMD) Valuation Following Strategic Medcase Collaboration in Healthcare AI DataOctober 11, 2025 OneMedNet (ONMD) is making headlines after announcing a strategic partnership with Medcase, a global leader in medical data…